Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Change To Liabilities

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Change-To-Liabilities" stands at -15.02 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2024, the highest value since 12/31/2022.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 32.82 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 32.82 Billion Japanese Yens.
The 3 year change is -49.94 Billion Japanese Yens.
The 5 year change is 51.34 Billion Japanese Yens.

The Serie's long term average value is -7.91 Billion Japanese Yens. It's latest available value, on 06/30/2024, is -7.11 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2023, to it's latest available value, on 06/30/2024, is +129.95 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 03/31/2022, to it's latest available value, on 06/30/2024, is -140.18 Billion.

Change To Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Change To Liabilities905,699,262,464.00
LogoJohnson & Johnson - Change To Liabilities486,508,953,600.00
LogoAbbVie Inc - Change To Liabilities399,570,305,024.00
LogoRoche Holding AG - Change To Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Change To Liabilities280,205,508,085.11